Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases Central Excise Central Excise + AT Central Excise - 2013 (9) TMI AT This

  • Login
  • Cases Cited
  • Referred In
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2013 (9) TMI 245 - AT - Central Excise


Issues Involved:
1. Allegation of suppression of production and clandestine removal of goods.
2. Evidentiary value of statements and retractions.
3. Corroborative evidence supporting clandestine activities.
4. Compliance with statutory requirements and maintenance of records.
5. Assessment of penalties and interest.

Issue-wise Detailed Analysis:

1. Allegation of Suppression of Production and Clandestine Removal of Goods:
The case involved allegations against M/s Centurian Laboratories (M/s CL) for suppression of production and clandestine removal of finished goods without accounting them in statutory records. During a search operation, incriminating documents were seized, leading to a show cause notice demanding duty on the purportedly clandestinely manufactured and cleared goods. The adjudicating authority confirmed the demand along with interest and penalties.

2. Evidentiary Value of Statements and Retractions:
The adjudicating authority relied heavily on the statements of key personnel from M/s CL, including Shri Shah, Shri A.D. Parmar, and Shri A.V. Patel. The appellants contended that these statements were retracted immediately through affidavits. The Tribunal noted that the adjudicating authority did not adequately consider these retractions, which were communicated to the DGCEI soon after the statements were recorded. The Tribunal emphasized that mere confessional statements, especially when retracted, are insufficient to substantiate allegations of clandestine removal.

3. Corroborative Evidence Supporting Clandestine Activities:
The Tribunal found that the Revenue failed to provide corroborative evidence to support the allegations. It highlighted the absence of statements from raw material suppliers or purchasers of the finished goods. The investigation did not extend to verifying statutory records required by the Food & Drug Administration (FDA), which could have provided critical evidence. The Tribunal noted that the records maintained by M/s CL were consistent with statutory requirements and there was no evidence of unaccounted raw materials or finished goods.

4. Compliance with Statutory Requirements and Maintenance of Records:
The Tribunal scrutinized the records maintained by M/s CL, including batch registers and RG-1 registers. It found that the theoretical batch sizes recorded did not necessarily reflect actual production due to potential losses during manufacturing. The Tribunal criticized the lack of investigation into FDA-mandated records, which are crucial for pharmaceutical manufacturers. The absence of discrepancies in these records further weakened the Revenue's case.

5. Assessment of Penalties and Interest:
Given the lack of substantial evidence and the reliance on retracted statements, the Tribunal concluded that the penalties and interest imposed were unsustainable. It underscored the need for tangible evidence to support allegations of clandestine activities. The Tribunal's decision to set aside the impugned order and allow the appeals with consequential relief was based on the principle that allegations must be substantiated by credible and corroborative evidence.

Conclusion:
The Tribunal's judgment emphasized the importance of corroborative evidence in cases of alleged clandestine removal and highlighted the inadequacy of relying solely on retracted statements. The decision underscored the necessity for thorough investigations and adherence to statutory requirements in substantiating such allegations. The appeals were allowed, and the impugned order was set aside, providing consequential relief to the appellants.

 

 

 

 

Quick Updates:Latest Updates